(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GENMAB

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GENMAB

ST13

US500000079040923

Class

42

Filing

79040923

Registration

3431559

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

03/21/2025

Trademark type

Word

Nice classes

42

Filing date

12/14/2006

Registration date

05/20/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/19/2018

Last transaction

06/05/2024

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

84

Owner location

DK

Examiner

MORRIS, KRISTINA

Law office

M70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Genmab A/S

Representatives

Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medical scientific researchbiological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancerAIDSacquired immune deficiency syndromeother infectious diseasesimmune and autoimmune diseasesinflammatory diseases and cardiovascular diseases; chemical analysis; patent exploitationpatent licensing; licensing of intellectual property in the field of medicine; computer programmingprogramming of computers for the collection and processing of medical data in medical scientific researchdevelopment and therapy with monoclonal antibodies

Publications

History of USPTO decisions and trademark events.

49 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/21/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

06/05/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/05/2024

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

06/05/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/05/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/05/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/05/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/05/2024

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

09/15/2023

RNWL

INTERNATIONAL REGISTRATION RENEWED

02/25/2021

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

11/19/2018

71AG

REGISTERED-SEC.71 ACCEPTED

11/19/2018

ES71

TEAS SECTION 71 RECEIVED

11/14/2018

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

10/26/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

09/08/2017

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

05/20/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/20/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/09/2017

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

02/09/2017

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

06/04/2014

71AG

REGISTERED-SEC.71 ACCEPTED

06/03/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/02/2014

71AF

REGISTERED-SEC.71 FILED

05/15/2014

ES71

TEAS SECTION 71 RECEIVED

05/15/2014

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/29/2012

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/11/2011

RNWL

INTERNATIONAL REGISTRATION RENEWED

03/04/2011

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

07/15/2010

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/10/2008

FIMP

FINAL DISPOSITION PROCESSED

09/10/2008

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/21/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

05/20/2008

PUBO

PUBLISHED FOR OPPOSITION

03/04/2008

NPUB

NOTICE OF PUBLICATION

02/13/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/30/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/28/2008

ACEC

AMENDMENT FROM APPLICANT ENTERED

01/10/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/10/2008

ALIE

ASSIGNED TO LIE

01/10/2008

MAIL

PAPER RECEIVED

11/28/2007

RFNT

REFUSAL PROCESSED BY IB

09/14/2007

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/27/2007

RFRR

REFUSAL PROCESSED BY MPU

08/27/2007

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/26/2007

CNRT

NON-FINAL ACTION WRITTEN

08/25/2007

DOCK

ASSIGNED TO EXAMINER

08/21/2007

NWAP

NEW APPLICATION ENTERED

08/21/2007

LIMS

LIMITATION OF GOODS/SERVICES FROM IB ENTERED

08/20/2007

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

08/16/2007

Continuous trademark protection

Get notified about every new filing that threatens GENMAB or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.